Skip to main content
SpringerLink
Log in

Erwartungen des Psychiaters an die Rezeptoren-SPECT des Gehirns

  • Chapter
Single-Photon-Emissions-Computertomographie (SPECT) des Gehirns

  • 28 Accesses

Zusammenfassung

Bei Vorgabe dieses Titels durch den Herausgeber ist man geneigt, z.Z. noch utopische Erwartungen zu formulieren. Wünschenswert wäre, mit Rezeptor-SPECT eine ubiquitär verfügbare, einfach einzusetzende und quantifizierbare Messung verschiedener Rezeptorsysteme des Gehirns zu ermöglichen. Dabei sollte die Untersuchung gerade für psychiatrische Patienten mit möglichst kurzer Untersuchungszeit und ohne invasive Methoden (z.B. arterielle Blutabnahmen) einhergehen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Dewey SL, Smith GS, Alexoff D et al. (1994) Studies of the interactions of dopamine with other neurotransmitters: PET and in vivo microdialysis experiments. Neuropsychopharmacol 10:81S

    Google Scholar 

  2. Kung H, Pan S, Kung MP et al. (1989) In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D2-dopamine receptor imaging agent. J Nucl Med 30:88–92

    PubMed  CAS  Google Scholar 

  3. Kung HF, Alavi A, Chang W, Kung MP et al. (1990) In vivo SPECT imaging of CNS D2 dopamine receptors: Initial studies with iodine-123-IBZM in humans. J Nucl Med 31:573–579

    PubMed  CAS  Google Scholar 

  4. Brücke T, Podreka I, Angelberger P et al. (1991) Dopamin D2 receptor imaging with SPECT: Studies in different neuropsychiatric disorders. J Cereb Blood Flow Metab 11:220–228

    Article  PubMed  Google Scholar 

  5. Wong DF, Wagner HN, Tune LE, Dannais RF, Pearlson GD et al. (1986) Positron Emission Tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 234:1558–1563

    Article  PubMed  CAS  Google Scholar 

  6. Farde L, Wiesel FA, Stone-Elander S, Halldin C, Nordström AL, Hall H, Sedvall G (1990) D2 dopamine receptors in neuroleptic-naive schizophrenic patients. Arch Gen Psychiatry 47:213–218

    PubMed  CAS  Google Scholar 

  7. Seeman P, Hong-Chang G, Van Tol HHM (1993) Dopamine D4 receptors elevated in schizophrenia. Nature 365:441–445

    Article  PubMed  CAS  Google Scholar 

  8. Schlößer R, Schlegel S (to be published) D2-Receptor imaging with 123I-IBZM and single photon emission tomography in psychiatry: a survey of current status. J Neurol Transm

    Google Scholar 

  9. Pilowsky LS, Costa DC, Ell PJ, Murray RM, Verhoeff NPLG, Kerwin RW (1992) Clozapine, single photon emission tomography and the D2 dopamine receptor blockade hypothesis of schizophrenia. Lancet 340:199–202

    Article  PubMed  CAS  Google Scholar 

  10. Pilowsky LS; Costa DC, Ell PJ, Murray RM, Verhoeff NPLG, Kerwin RW (1993) Antipsychotic medication, D2 dopamine receptor blockade and clinical response: a 1231 IBZM SPET (single photon emission tomography) study. Psychological Medicine 23:791–797

    Article  PubMed  CAS  Google Scholar 

  11. Tatsch K, Schwarz J, Kerner M, Oertel WH, Kirsch CM (1993) Idiopathisches Parkinson Syndrom: 123-J-IBZM SPECT vor und unter Therapie. Nucl Med 32:A13

    Google Scholar 

  12. Klemm E, Kasper S, Broich K, Danos P, Grünwald F, Menzel C, Hotze AL, Krappel C, Möller HJ, Biersack HJ (1993) 123I-IBZM-SPECT for imaging of striatal D2-dopamine receptors and clinical variables in psychiatric patients with different diagnosis. Pharmacopsychiatry 26:168

    Google Scholar 

  13. Grünwald F, Danos P, Kasper S, Briele B, Klemm E, Möller HJ, Biersack HJ (1992) IBZM-SPECT bei psychiatrischen Erkrankungen. Nucl Med 31:A82

    Google Scholar 

  14. Schlegel S, Steinert H, Nickel O, Schlößer R, Hiemke Ch, Wetzel H, Fischer S, Hahn K (1993) IBZM- SPECT bei Neuroleptikatherapie. In: Baumann P (Hrsg) Biologische Psychiatrie der Gegenwart. Springer, Wien, New York, S520–522

    Google Scholar 

  15. D’Haenen H, Bossuyt A (1994) Dopamine D2 receptors in depression measured with single photon emission computed tomography. Biol Psychiatry 35:128–132

    Article  PubMed  Google Scholar 

  16. Geaney DP, Ellis PM, Soper N, Shepstone BJ, Cowen P (1992) Single Photon Emission Tomography assessment of cerebral dopamine D2 receptor blockade in schizophrenia. Biol Psychiatry 32:293–295

    Article  PubMed  CAS  Google Scholar 

  17. Farde L, Wiesel FA, Halldin C, Sedvall G (1988) Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry 45:171–76

    Google Scholar 

  18. Laruelle M, van Dyck C, Abi-Dargham A, Zea-Ponce Y, Zoghbi SS, Charney DS, Baldwin RM, Hoffer PB, Kung HF, Innis RB (1994) Compartmental modeling of iodine- 123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects. J Nucl Med 35:743–754

    PubMed  CAS  Google Scholar 

  19. Kung HF (1993) SPECT and PET ligands for CNS imaging. Neurotransmissions IX:l-8

    Google Scholar 

  20. Brücke T, Kornhuber J, Angelberger P, Asenbaum S, Frassine H, Podreka I (1993) SPECT imaging of dopamine and serotonin transporters with [123]beta-CIT. Binding kinetics in the human brain. J Neural Transm Gen Sect 94:137–146

    Article  PubMed  Google Scholar 

  21. Laruelle M, Baldwin RM, Malison RT, Zea-Ponce Y, Zoghbi SS, AI-Trikriti MS, Sybirska EH, Zimmermann RC, Wisniewski G, Neumeyer JL et al. (1993) SPECT imaging of dopamine and serotonin transporters with [123]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse 13:295–309

    Article  PubMed  CAS  Google Scholar 

  22. Madras BK (1994) Novel probes for imaging the dopamine transporter. Neuropsychophar- macology 10:80S

    Google Scholar 

  23. Davis KI, Kahn RS, Ko G, Davidson M (1991) Dopamine in schizophrenia: A review and reconceptualisation. Am J Psychiatry 148:1474–1486

    PubMed  CAS  Google Scholar 

  24. Farde Li Suhara T, Halldin C et al. (1994) PET-study of extrastriatal dopamine receptors in the human brain. Neuropsychopharmacol 10:78S

    Google Scholar 

  25. Beer HF, Blaeuenstein PA, Hasler PH et al. (1990) In vitro and in vivo evaluation of iodine-123-RO 16–0154: a new imaging agent for SPECT investigations of benzodiazepine receptors. J Nucl Med 31:1007–1014

    PubMed  CAS  Google Scholar 

  26. Innis RB, AI-Tikriti MS, Zoghbi SS et al. (1991) SPECT imgaging of the benzodiazepine receptor: Feasibility of in vivo potency measurements from stepwise displacement curves. J Nucl Med 32:1754–1761

    PubMed  CAS  Google Scholar 

  27. Mueller WE (1987) The benzodiazepine receptor. Cambridge University Press. New York

    Google Scholar 

  28. Persson A, Pauli S, Halldin C, Stone-Elander S, Farde L, Sjögren I, Sedvall G (1989) Saturation analysis of specific nC Ro 15–1788 binding to the human cortex using positron emission tomography. Hum Psychopharmacol 4:21–31

    Article  Google Scholar 

  29. Schlegel S, Steinert H, Bockisch A, Hahn K, Schlößer R, Benkert O (1994) Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT: A preliminary report. Eur Arch Psychiatry Clin Neurosci 244:49–51

    Article  PubMed  CAS  Google Scholar 

  30. Schlegel S, Steinert H, Nickel O, Bockisch A, Schlößer R, Hahn K (1993) Benzodia- zepinrezeptordichte bei Depression im lomazenil-SPECT. Nucl Med 32:16

    Google Scholar 

  31. Cheetham SC, Crompton MR, Katona CLE, Parker SJ, Horton RW (1988) Brain GABA a / benzodiazepine binding sites and glutamatic acid decarboxylase activity in depressed suicide victims. Brain Res 460:114–123

    Article  PubMed  CAS  Google Scholar 

  32. Laruelle M, Abi-Dargham A, Rattner Z et al. (1993): Single photon emission tomography measurement of benzodiazepine receptor number and affinity in primate brain: a constant infusion paradigm with (123I)iomazenil. Eur J Pharmacology 230:119–123

    Article  CAS  Google Scholar 

  33. Schlegel S, Schlößer R (to be published) Benzodiazepine receptor binding measured by IOMAZENIL-SPECT: Summary of different studies.

    Google Scholar 

  34. D’Haenen H, Bossuyt A, Mertens J, Bossuyt-Piron C, Gijsemans M, Kaufman L (1992) SPECT imaging of serotonin2 receptors in depression. Psychiatry Res 45:227–237

    Article  PubMed  Google Scholar 

  35. Jagust WJ, Eberlin JL, Roberts JA et al. (1993) In vivo imaging of the 5-hydroxytryptamine reuptake site in primate brain using single photon emission computed tomography and [123]5-iodo-6- nitroquipazine. Eur J Pharmacol 242:189–193

    Article  PubMed  CAS  Google Scholar 

  36. Holnian LB, Gibson RE, Hill TC, Eckelman WC, Albert MA, Reba RC (1985) Muscarinic acetylcholine receptors in Alzheimer’s disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl- 4-iodobezilate and emission tomography. JAMA 2254:3063–3066

    Article  Google Scholar 

  37. Weinberger DR, Gibson R, Coppola R, Jones DW, Molchan S, Sunderland T, Ferman KF, Reba RC (1991) The distribution of cerebral muscarinic acetylcholine receptors in vivo in patients with dementia. Arch Neurol 48:169–176

    PubMed  CAS  Google Scholar 

  38. Weinberger DR (1993) SPECT imaging in psychiatry: introduction and overview. J Clin Psychiatry 54[Suppl]:3–5

    PubMed  Google Scholar 

  39. Müller-Gärtner HW, Wilson AA, Dannais RF, Wagner HN Jr, Frost J J (1992) Imaging muscarinic cholinergic receptors in human brain in vivo with SPECT [123]4-iododexetimide, and [123]4- iodolevetimide. J Cereb Blood Flow Metab 12:562–570

    Article  PubMed  Google Scholar 

  40. He XS, Bowen WD, Lee KS, Williams W, Weinberger DR, de Cost BR (1993) Synthesis and binding characteristics of potential SPECT imaging agents for sigma-1 and sigma-2 binding sites. J Med Chem 36:566–571

    Article  PubMed  CAS  Google Scholar 

  41. Garner SE, Kung MP, Foulon C, Chumpradit S, Kung HF (1994) [125](S)-trans-7-OH-PIPAT: a potential SPECT imaging agent for sigma binding sites. Life Sci 54:593–603

    Article  PubMed  CAS  Google Scholar 

  42. Bowen WD (1994) Sigma receptor-mediated cytotoxicity: sigma ligands produce changes in cell morphology and viability. Neuropsychopharmacology 10:836S

    Google Scholar 

  43. Shibuya H, Mori H, Toru M (1994) Sigma receptors in the postmortem schizophrenic brains. Neuropsychopharmacology 10:839S

    Google Scholar 

  44. Verhoeff NPLG (1991) Pharmacological implications for neuroreceptor imaging. Eur J Nucl Med 18:482–502

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. S. Schlegel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abt. Nuklearmedizin, Bundeswehrzentralkrankenhaus Koblenz, Rübenacherstr. 170, 56072, Koblenz, Germany

    H. J. Wieler (Leitender Arzt) (Leitender Arzt)

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schlegel, S. (1995). Erwartungen des Psychiaters an die Rezeptoren-SPECT des Gehirns. In: Wieler, H.J. (eds) Single-Photon-Emissions-Computertomographie (SPECT) des Gehirns. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79222-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-79222-9_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-79223-6

  • Online ISBN: 978-3-642-79222-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation